Barbara Slusher explains the hit-to-lead optimization process, high-throughput screening, and the role of AI and organoids in ...

Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced ...

The first core area involved improving the medical center's culture and systems for using unique patient identifiers and wristbands. In 2003, the medical center launched initiatives to identify ...

Target identification is a critical and challenging step in drug discovery, with only a small fraction of human genes considered druggable and even fewer successfully targeted by approved therapies.

Relief is coming for crime scene investigators and toxicologists who have struggled to accurately and swiftly identify drugs that have been seized by law enforcement and may be relied on as evidence ...